ArticleViruses2023

Efficacy of Remdesivir and Neutralizing Monoclonal Antibodies in Monotherapy or Combination Therapy in Reducing the Risk of Disease Progression in Elderly or Immunocompromised Hosts Hospitalized for COVID-19: A Single Center Retrospective Study.

Davide Fiore Bavaro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.